Metabolic complications and altered fat distribution associated with HIV infection and
antiretroviral therapy may lead to accelerated coronary artery disease (CAD). The high …

The use of new potent protease inhibitor-based antiretroviral therapies in patients with
human immunodeficiency virus (HIV) infection has been increasingly associated with …

Background: Metabolic syndrome (MS) identifies individuals at risk of cardiovascular
disease (CVD) and type 2 diabetes mellitus (T2DM). Little is known about MS and its …

Background This systematic review aimed to compare body weight gain associated
outcomes over time between dolutegravir (DTG)-based antiretroviral (ART) regimens to …

HIV infection and antiretroviral therapy (ART) treatment exert diverse effects on adipocytes
and stromal-vascular fraction cells, leading to changes in adipose tissue quantity …

Metabolic changes characteristically observed with HIV infection include low total and high-
density lipoprotein (HDL) cholesterol and elevated triglycerides. Initiation of antiretroviral …

The contribution of current antiretroviral treatment regimens to the long-term survival of HIV-
infected individuals is accompanied by increased risk of glucose metabolism abnormalities …

Human immunodeficiency virus (HIV) is a chronic disease associated with dyslipidemia and
insulin resistance. In addition, the administration of combination antiretroviral therapy is …